Taming the dragon: managing chronic pain
In 2019, Nicola Filzmoser (PGDE 2019) co-founded Happyr Health, an app to help young people manage chronic pain. Nicola spoke to us about her motivation and goals. Chronic pain can have a massive impact on everyday life. In addition to…
Why flaws can pay: entrepreneurs need not seem perfect in seeking investors
Entrepreneurs who expose flaws like insecurity can boost investment by attracting investors with similar flaws, finds study co-authored by Dr Jochen Menges of Cambridge Judge that won a top Academy of Management award. Dr Jochen Menges The stereotype of an…
Iponews studio: Zhiyun Health officially landed on the Hong Kong Stock Exchange with a market value of more than HK$17.3 billion
Zhiyun Health, a startup created by Ming Kuang, alumnus of Cambridge Judge Business School (MBA 2010) was officially listed on the Main Board of the Hong Kong Stock Exchange today, with Morgan Stanley and JPMorgan Chase & Co. as joint…
The EMBAs teaching the art of life or death decision making
Leading on the Frontline founders and Cambridge Judge Business School graduates tell of the trials and successes of setting up a new venture while undertaking their degree and working full-time. The word 'frontline' has never been more prominent. Throughout the…
Yahoo Finance: Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer
Spirea, a startup supported by the Accelerate Cambridge programme run by Cambridge Judge Business School’s Entrepreneurship Centre, has secured funding of £2.4 million with investments from high-profile UK and US investors. Dr Myriam Ouberai, Chief Executive Officer at Spirea, commented:…
Venturing forth: Qureight – integrating data with AI to solve complex diseases
Qureight, a clinical data analytics company supported by the Accelerate Cambridge programme at Cambridge Judge Business School, just raised £1.5m in seed funding. Qureight, a clinical data analytics firm supported by Cambridge Judge Business School, had its origins in a…
Venturing forth: bit.bio – reprogramming stem cells to allow manufacture of human cells
Biotech firm bit.bio, which was on the Accelerate Cambridge programme at Cambridge Judge Business School, reprograms stem cells to allow manufacture of human cells. Mark Kotter Mark Kotter, a University of Cambridge stem cell biologist and neurosurgeon who founded biotech…
Scratching the surface
Meal kit company Gousto, founded by Cambridge Judge Business School alumnus, reaches 'unicorn' $1bn valuation and says the boom in online food will continue after the pandemic. Timo Boldt Founded by Timo Boldt, an alumus of the Executive MBA programme…
From Breakthrough to Blockbuster
New book co-authored by Nektarios Oraiopoulos of Cambridge Judge Business School charts the rise of entrepreneurial biotech firms. Dr Nektarios Oraiopoulos From Breakthrough to Blockbuster: The Business of Biotechnology, published today, shows how the small, inexperienced entrepreneurial companies making up…
Female entrepreneurship: what’s holding women back?
Mark Zuckerberg, Jeff Bezos, Bill Gates, Steve Jobs – take a quick look at some of the biggest names in entrepreneurial history and it's hard to avoid the fact men make up the overwhelming majority. That's not to say there…
